Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): Y.H. Park, H.S. Rugo, N. Chittoria, R. Sacks, J. Chiu, C. Murphy, O. Ayodele, G.M. Kim, K.S. Lee, W. Xu, R. Joshi, A. Kwong, M. Dong, Y. Zhang, R. Rong, E. Lopez Rodrigo, N. Rainey, S. Adams
Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer☆. // ESMO Open. – URL: https://www.sciencedirect.com/science/article/pii/S2059702926025457?dgcid=rss_sd_all
Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer☆. ESMO Open. https://www.sciencedirect.com/science/article/pii/S2059702926025457?dgcid=rss_sd_all
“Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer☆.” ESMO Open.
@article{article89124,
title = {Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer☆},
journal = {ESMO Open},
url = {https://www.sciencedirect.com/science/article/pii/S2059702926025457?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment